New combo treatment targets returned prostate cancer
NCT ID NCT03553602
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a treatment for prostate cancer that came back after previous radiation. It combined temporary radioactive implants placed in the prostate, daily external radiation to the pelvis for 5 weeks, and 6 months of hormone therapy. The goal was to see if this approach could control the cancer and what side effects might occur. Only 3 people took part before the study was stopped early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- Prostate cancer disparities: uncovering the hidden drivers
- MRI-Guided radiation: a sharper weapon against prostate cancer?
- AI learns from 14,000 prostate scans to spot aggressive cancers
- New hope for prostate cancer recurrence: precise radiation without major surgery
- Can a 2-week drug boost scan accuracy for hidden prostate cancer?